Skip to content
10-Q

Quarterly Report

IRONWOOD PHARMACEUTICALS INC IRWD

0001104659-26-057110

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 164.61M sh
Shares Diluted Q1 2026 · Mar 31, 2026 166.69M sh
Shares Diluted Q1 2026 · Mar 31, 2025 160.97M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 $5.12M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $19.95M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $220.47M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $215.46M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$217.14M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$261.84M
Current Liabilities Q1 2026 · Mar 31, 2026 $236.31M
Current Liabilities Q1 2026 · Dec 31, 2025 $242.22M
Current Assets Q1 2026 · Mar 31, 2026 $332.29M
Current Assets Q1 2026 · Dec 31, 2025 $274.18M
Total Assets Q1 2026 · Mar 31, 2026 $434.57M
Total Assets Q1 2026 · Dec 31, 2025 $396.9M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.24
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.23
Eps Basic Q1 2026 · Mar 31, 2026 $0.25
Eps Basic Q1 2026 · Mar 31, 2025 −$0.23
Sga Expense Q1 2026 · Mar 31, 2026 $12.03M
Sga Expense Q1 2026 · Mar 31, 2025 $24.26M
Rd Expense Q1 2026 · Mar 31, 2026 $21.94M
Rd Expense Q1 2026 · Mar 31, 2025 $27.43M
Net Income Q1 2026 · Mar 31, 2026 $40.77M
Net Income Q1 2026 · Mar 31, 2025 −$37.39M
Operating Income Q1 2026 · Mar 31, 2026 $72.57M
Operating Income Q1 2026 · Mar 31, 2025 −$29.11M
Revenue Q1 2026 · Mar 31, 2026 $106.51M
Revenue Q1 2026 · Mar 31, 2025 $41.14M
Capex Q1 2026 · Mar 31, 2025 $31K